March 20, 2025
Decades of infectious disease research have shaped gene therapy by refining immune modulation—while vaccines stimulate immunity, gene therapy must avoid immune activation for safety. These insights, alongside public health infrastructure, have accelerated gene therapies for SMA, vision loss, and infectious diseases. With vaccine-based manufacturing and regulatory pathways, gene therapy is now poised to deliver transformative treatments worldwide.